Source: Financial Modeling Prep · peers by sector/industry
Insider activity (SEC Form 4)
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Valuation
Trading at 0.8× earnings vs its 0.5× historical median P/E.
Fair value ≈ $10.08 · price $16.17 today
Overvalued · 60% above
Loading valuation…
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
$SPY $BACHY $FXI The United States sent letters to two Chinese banks warning them of the risk of secondary sanctions if they are found to be supporting transactions tied to Iran.
Strong open for $BACHY — bulls in control early on.
But check this company — expanding from colorectal to pancreatic cancer with ColoAlert® showing 97% sensitivity. Strong trials, key partnerships, and FDA plans point to major U.S. growth in early cancer detection.
https://ritzherald.com/colorectal-to-pancreatic-mainz-biomed-expands-reach-in-early-cancer-detection/
$BACHY earnings incoming! Analysts have mixed vibes—will it pop the champagne or grab popcorn? Past reports swung like a pendulum, but hey, yellow highlights don’t lie. Stay tuned.
I found you an Overbought RSI (Relative Strength Index) on the daily chart of Bank of China Ltd ADR. Is that bullish or bearish? $BACHY #RsiOverbought #PINK
I found you an Overbought RSI (Relative Strength Index) on the daily chart of Bank of China Ltd ADR. Is that bullish or bearish? $BACHY #RsiOverbought #PINK
$BACHY - Bank Of China has high likelihood to experience some financial distress in the next 2 years https://www.macroaxis.com/stock-analysis/BACHY/Bank-Of-China #insidertrading #stocks #fintechnews
